Bill Few Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bill Few Associates's BMY Position: Q3 2026 in Review
Bill Few Associates increased its Bristol-Myers Squibb (BMY) stake by 3.8% in Q3 2026, buying an estimated $28.5K and bringing the position to 12,327 shares worth $769K. The position accounts for 0.16% of the portfolio, ranked #106.
Bill Few Associates first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Bill Few Associates held 12,327 shares of Bristol-Myers Squibb worth $769K as of Q3 2026.
- Bill Few Associates bought 451 Bristol-Myers Squibb shares in Q3 2026, an estimated $28.5K.
- Bristol-Myers Squibb made up 0.16% of Bill Few Associates's portfolio in Q3 2026, its #106 holding.
- Bill Few Associates first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.